PHA6123 - Survey Research, Meta-Analysis, Etc.
PHA6123 - Survey Research, Meta-Analysis, Etc.
PHA6123 - Survey Research, Meta-Analysis, Etc.
Department of Pharmacy, University of Santo Tomas Bugayong & Alcazar (3APH) | Page 1 of 6
Survey Research, Meta-Analysis, Practice Guidelines, and Health Outcomes Research
Department of Pharmacy, University of Santo Tomas Bugayong & Alcazar (3APH) | Page 2 of 6
Survey Research, Meta-Analysis, Practice Guidelines, and Health Outcomes Research
such as faulty questions, flawed response options, ∙ only articles published in the author’s
or interviewer training deficiencies primary language are used
∙ ex. German author
REVIEW ARTICLES AND META-ANALYSIS
3. Selection Bias
REVIEW ARTICLES
∙ to reduce selection bias, authors must be blinded to:
∙ classified as tertiary literature and may be subject to 1. Names of the Study Authors (to avoid political or
author biases or inaccuracies in the literature search personal issues)
∙ Meta-Analyses ∙ 2 or more authors should critic it in
∙ despite being classified as a review article is consideration and all evaluators concur on
considered as a primary literature because it which studies will be included in the
generates new data and findings from previous systematic review
researches 2. Institution of Publication
3. Results of the Studies
TYPES ∙ for the initial choice of study inclusion, only the
methods section should be reviewed
∙ tertiary except meta-analysis although used as
secondary because they can lead readers to primary Meta-Analysis (Quantitative Review)
references
1. Narrative or Non-systematic Review (Qualitative ∙ widely used to provide supporting evidence for clinical
review) decision making or in areas of conflicting evidences by
2. Systematic Review (Qualitative review) combining results of previous researchers and re-
3. Meta-Analysis (Quantitative review) analyzing them as a whole new data set
∙ widely used in providing support in clinical
Narrative or Non-Systematic Review (Qualitative Review) decisions
∙ analytical technique to combine data from multiple
∙ summary of research that lacks a description of
studies
systematic methods (e.g., system of literature search
and inclusion) Types
∙ ex. pharmacy therapeutics committee
∙ may pertain to one specific clinical question or disease 1. Pairwise Meta-Analysis
state, or to topics related to pharmacy administration ∙ this is the traditional method of synthesizing the
results of different trials to obtain an overall
Systematic Review (Qualitative Review) estimate of the treatment effect of one
intervention relative to the control
∙ subjects for this review are scientific investigations
with predefined methods and original studies
2. Network Meta-Analysis
∙ summary of results of primary studies where the
∙ aka multiple treatment comparison or the mixed
results are not statistically combined
treatment meta-analysis
∙ defined as a research summary conducted in an
∙ network of randomized controlled trials is
organized and reproducible manner that addresses a
developed where all these trials have one
clinical question
intervention in common
∙ should be developed in a responsible manner with the
∙ simultaneously compares and ranks a network of
highest level of integrity
treatments in which the sub-sets have been
compared in individual studies
∙ can commonly be affected by these biases:
1. Publication Bias Uses
∙ publication selection for systematic review
∙ when published studies are given more 1. supporting or refuting lesser quality evidence
consideration because they are positive in 2. overcoming reduced statistical power of small studies
nature than unpublished studies 3. assessing occurrence of rare events
∙ Drawback of Unpublished Studies 4. providing guidance with limited/conflicting data
∙ have likely not undergone a peer-review 5. displaying sample sizes and treatment effects
and revision process; errors and unclearly graphically
stated conclusions may be present 6. assessing heterogeneity between studies and
2. Language Bias publication bias
7. evaluating the natural history of disease
Department of Pharmacy, University of Santo Tomas Bugayong & Alcazar (3APH) | Page 3 of 6
Survey Research, Meta-Analysis, Practice Guidelines, and Health Outcomes Research
8. improving estimates of effect size ∙ common statistical tests used to combine and
9. answering new questions not posed at the start of analyze the data:
individual trials ∙ Mantel-Haenszel test for categorical data
∙ Inverse Variance test for continuous data
Issues
Forest Plot
1. Publication Bias
∙ studies that show lack of efficacy are less likely to ∙ common method to present the results of a meta-
be located than those that demonstrate beneficial analysis
effects of a drug
∙ identified by funnel plots
∙ Funnel Plots
∙ scatterplot of treatment effect versus sample
size of the studies included in the meta-
analysis
∙ form of selection bias – wherein it is based on the
magnitude or direction or statistical significant of
the result
∙ most of the documented occurrence, many
researchers are more likely to publish studies that
demonstrate positive effects of drugs therefore it
is most likely to be located
Sensitivity Analysis
Department of Pharmacy, University of Santo Tomas Bugayong & Alcazar (3APH) | Page 4 of 6
Survey Research, Meta-Analysis, Practice Guidelines, and Health Outcomes Research
∙ provides information regarding therapeutic options ∙ important because this is where we see
and most appropriate choices for a specific disease the overall impact of the treatment or
and patient intervention towards the patient’s life
∙ research has shown that within 2 years of and lifestyle
development, a practice guideline may become
outdated, and must be updated ∙ Quality-Of-Life Measures
∙ Clinical Practice Guidelines ∙ focuses on the patient’s perception of well-being
∙ statements that include recommendations ∙ most important outcome in disease specific
intended to optimize patient care that are states
informed by a systematic review of evidence and ∙ multidimensional concept focusing on impact of a
an assessment of the benefits and harms of disease and treatment relative to the well-being
alternative care options (Institute of Medicine) of a patient
∙ subjective evaluation of both positive and
Types
negative characteristic of an individual life
∙ health-related quality-of-life (HR-QOL)
1. Evidence-Based
∙ value assigned to quality and quantity of life
∙ utilize a rigorous systematic process involving
that is affected by many different variables
review and critical evaluation of the medical
including: disease, injury, treatment, or
literature to develop final recommendations
health and insurance policies
2. Formal Consensus-Based
∙ used to assist in decision making regarding
∙ utilize experience of experts in their practice area
interventions such as procedures and
to draw conclusions and develop
pharmacotherapy of patients
recommendations
∙ useful for those instances where the evidence Two Types of HR-QOL Measurements
does not exist, is not complete, or not conclusive
enough to allow the development of a final 1. Health Status Assessment
recommendation ∙ self-assessment that measures multiple aspects of
3. Mixture of EBM and Consensus-Based a patient’s perceived wellbeing
∙ uses evidence to construct the guideline and ∙ assessment is primarily designed to either
supplements those steps without evidence with compare groups of patients receiving different
experience of the experts in that field treatments or effect of a treatment for a single
∙ useful especially in areas of practice where no group over time
established evidence or proof is available to be ∙ questions used ranges from perceived impact of
the standard of practice disease and treatments to disease frequency and
severity
Practice guidelines are created primarily for: ∙ most often used in clinical trials comparing
treatment regimen
✓ facilitating clinical decision making
2. Patient Preference Assessment
✓ improving the quality of health care
∙ reflect an individual’s decision-making process at
✓ providing consistent treatment across environments
a time when the eventual outcome is unknown
✓ decreasing costs
∙ measures the patient’s trade-off between quality
✓ diminishing professional liability
and quantity of life
✓ identifying individualized alternative treatment
Quality-Adjusted Life Years (QALYs) Gained from an
HEALTH OUTCOMES RESEARCH
Intervention
∙ Health Outcomes Research
∙ literatures directed into studying the impact of
treatments or intervention to the daily lives of
patients, it encompasses literatures for:
∙ pharmacoeconomic outcomes
∙ therapeutic outcomes
∙ non-therapeutic outcomes (such as number
of visits to the emergency room and number
of hospital admissions)
∙ quality-of-life (QOL) outcomes
Department of Pharmacy, University of Santo Tomas Bugayong & Alcazar (3APH) | Page 5 of 6
Survey Research, Meta-Analysis, Practice Guidelines, and Health Outcomes Research
Department of Pharmacy, University of Santo Tomas Bugayong & Alcazar (3APH) | Page 6 of 6